The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

Rheumatoid Arthritis Clinical Trial

Official title:

The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03483597
• Other study ID #: CRDC-satisfaction
• Status: Completed
• Start date: March 31, 2018
• Est. completion date: April 30, 2018

Study information

• Verified date: March 2018
• Source: Chinese SLE Treatment And Research Group
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Description:

In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1365
• Est. completion date: April 30, 2018
• Est. primary completion date: April 30, 2018
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months

Exclusion Criteria:

Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis
• Satisfaction

Intervention

Other:
• TSQM-II
Treatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups

Locations

Country	Name	City	State
China	Peking Union Medical College Hospital	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Chinese SLE Treatment And Research Group

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total score of patient satisfaction	Total score of patient satisfaction	1 day
Secondary	Average score of patients for various treatment demands	Average score of patients for various treatment demands	1 day
Secondary	Average score of patients for long-term treatment demands	Average score of patients for long-term treatment demands	1 day
Secondary	Average score of patients for new drug demands	Average score of patients for new drug demands	1 day
Secondary	Total score of doctor satisfaction	Total score of doctor satisfaction	1 day
Secondary	Average score of doctors for various treatment demands	Average score of doctors for various treatment demands	1 day
Secondary	Average score of doctors for long-term treatment demands	Average score of doctors for long-term treatment demands	1 day
Secondary	Average score of doctors for new drug demands	Average score of doctors for new drug demands	1 day